Literature DB >> 24643365

Cerebral ischemic preconditioning reduces glutamate excitotoxicity by up-regulating the uptake activity of GLT-1 in rats.

Jianxue Gong1, Shujuan Gong, Min Zhang, Lianwei Zhang, Yuyan Hu, Yixian Liu, Wenbin Li.   

Abstract

Our previous study has shown that cerebral ischemic preconditioning (CIP) can up-regulate the expression of glial glutamate transporter-1 (GLT-1) during the induction of brain ischemic tolerance in rats. The present study was undertaken to further explore the uptake activity of GLT-1 in the process by observing the changes in the concentration of extracellular glutamate with cerebral microdialysis and high-performance liquid chromatography. The results showed that a significant pulse of glutamate concentration reached the peak value of sevenfold of the basal level after lethal ischemic insult, which was associated with delayed neuronal death in the CA1 hippocampus. When the rats were pretreated 2 days before the lethal ischemic insult with CIP which protected the pyramidal neurons against delayed neuronal death, the peak value of glutamate concentration decreased to 3.9 fold of the basal level. Furthermore, pre-administration of dihydrokainate, an inhibitor of GLT-1, prevented the protective effect of CIP on ischemia-induced CA1 cell death. At the same time, compared with the CIP + Ischemia group, the peak value of glutamate concentration significantly increased and reached sixfold of the basal level. These results indicate that CIP induced brain ischemic tolerance via up-regulating GLT-1 uptake activity for glutamate and then decreasing the excitotoxicity of glutamate.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24643365     DOI: 10.1007/s00726-014-1723-1

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  7 in total

Review 1.  Preconditioning in neuroprotection: From hypoxia to ischemia.

Authors:  Sijie Li; Adam Hafeez; Fatima Noorulla; Xiaokun Geng; Guo Shao; Changhong Ren; Guowei Lu; Heng Zhao; Yuchuan Ding; Xunming Ji
Journal:  Prog Neurobiol       Date:  2017-01-18       Impact factor: 11.685

2.  Sulbactam improves binding property and uptake capacity of glutamate transporter-1 and decreases glutamate concentration in the CA1 region of hippocampus of global brain ischemic rats.

Authors:  Wei-Wei Gu; Xin Cui; Li-Zhe Liu; Min Zhang; Wen-Bin Li; Xiao-Hui Xian
Journal:  Amino Acids       Date:  2021-10-30       Impact factor: 3.520

Review 3.  Cortical spreading depression-induced preconditioning in the brain.

Authors:  Ping-Ping Shen; Shuai Hou; Di Ma; Ming-Ming Zhao; Ming-Qin Zhu; Jing-Dian Zhang; Liang-Shu Feng; Li Cui; Jia-Chun Feng
Journal:  Neural Regen Res       Date:  2016-11       Impact factor: 5.135

4.  Ceftriaxone- and N-acetylcysteine-induced brain tolerance to ischemia: Influence on glutamate levels in focal cerebral ischemia.

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Beata Bystrowska; Lucyna Pomierny-Chamioło; Małgorzata Filip; Bogusława Budziszewska; Joanna Pera
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

5.  Hypoxic Preconditioning Maintains GLT-1 Against Transient Global Cerebral Ischemia Through Upregulating Cx43 and Inhibiting c-Src.

Authors:  Kongping Li; Huarong Zhou; Lixuan Zhan; Zhe Shi; Weiwen Sun; Dandan Liu; Liu Liu; Donghai Liang; Yafu Tan; Wensheng Xu; En Xu
Journal:  Front Mol Neurosci       Date:  2018-10-01       Impact factor: 5.639

6.  Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage.

Authors:  William A Kofke; Yue Ren; John G Augoustides; Hongzhe Li; Katherine Nathanson; Robert Siman; Qing Cheng Meng; Weiming Bu; Sukanya Yandrawatthana; Guy Kositratna; Cecilia Kim; Joseph E Bavaria
Journal:  Front Neurol       Date:  2018-06-26       Impact factor: 4.003

Review 7.  Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases.

Authors:  Jia Liu; Yakun Gu; Mengyuan Guo; Xunming Ji
Journal:  CNS Neurosci Ther       Date:  2021-08       Impact factor: 5.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.